Skip to main content
Phoom Narongkiatikhun on Muck Rack

Phoom Narongkiatikhun

As seen in: MDPI, The Journal of Clinical Investigation
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Phoom

Contact Phoom, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Unveiling mechanisms underlying kidney function changes during sex hormone therapy

|
By Laura Pyle, Phoom Narongkiatikhun, Ye Ji Choi, Wassim Obeid
| The Journal of Clinical Investigation
Clinical Research and Public HealthEndocrinologyNephrology Open Access | 10.1172/JCI190850 J Clin Invest. https://doi.org/10.1172/JCI190850. Copyright © 2025, van Eeghen et al. This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. View PDF Abstract Background: Men with chronic kidney disease (CKD) experience faster kidney function decline than women.
Open in Who Shared Issue with article?

Attenuated kidney oxidative metabolism in young adults with type 1 diabetes

|
By Ye Ji Choi, Gabriel Richard, Guanshi Zhang, Jeffrey B. Hodgin, Dawit Demeke, Yingbao Yang, Jennifer Schaub, Ian Tamayo, Abhijit Naik, Viji Nair, Phoom Narongkiatikhun, Susan Gross, Bhupendra K. Gurung, Carissa Birznieks, Alexis MacDonald
| The Journal of Clinical Investigation
Abstract Introduction Insulin resistance (IR) is prevalent in children and adults with type 1 diabetes (T1D) and often accompanies intensive glycemic therapy. The presence of IR may promote oxidative stress and inflammation, potentially contributing to mitochondrial dysfunction (1–4).
Open in Who Shared Issue with article?

Immunogenicity and Safety of Homologous and Heterologous Prime-Boost of CoronaVac® and ChAdOx1 nCoV-19 among Hemodialysis Patients: An Observational Prospective Cohort Study

|
By Kajohnsak Noppakun, Romanee Chaiwarith, Poramed Winichakoon, Phoom Narongkiatikhun
| MDPI
4. Discussion Since the risk of mortality from COVID-19 disease is known to be higher among MHD patients when compared with the general population, the implementation of preventive strategies using effective vaccines would be crucial. However, most clinical studies involving vaccines have generally excluded this group of patients. In this study, we investigated the degree of vaccine immunogenicity of SV-SV, AZ-AZ, and SV-AZ regimens among 130 MHD patients.
Open in Who Shared Issue with article?
See all 3 articles